<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We present a case of <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) following treatment for <z:hpo ids='HP_0002885'>medulloblastoma</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> was diagnosed at 15 years of age and managed with surgery, craniospinal radiation and a triple-drug regimen [chloroethylnitrosourea (CCNU), <z:chebi fb="0" ids="28445">vincristine</z:chebi> (VCR), procarbazine] </plain></SENT>
<SENT sid="2" pm="."><plain>Fifteen months after the completion of therapy, the patient developed <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> with <z:mp ids='MP_0004026'>monosomy</z:mp> 5 and <z:mp ids='MP_0004026'>monosomy</z:mp> 7 on chromosome analysis of bone marrow cells </plain></SENT>
<SENT sid="3" pm="."><plain>Two weeks later, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> evolved into <z:hpo ids='HP_0004808'>acute myeloblastic leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) </plain></SENT>
<SENT sid="4" pm="."><plain><z:e sem="disease" ids="C1292780" disease_type="Neoplastic Process" abbrv="">Therapy-related MDS</z:e> or <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> may be a complication for patients with past <z:mp ids='MP_0009277'>brain tumors</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>Therefore, they should be carefully followed up by regular physical examinations and complete blood counts </plain></SENT>
</text></document>